Back to search
Immune-Mediated Hepatitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Immune-Mediated Hepatitis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Immune-Mediated Hepatitis trials you may qualify forIn this multi-center prospective observational study, the investigators plan to identify the incidence and risk factors for checkpoint inhibitor-induced liver i…
Identify specific blood biomarkers for hepatitis induced by immune checkpoint inhibitors in comparison to idiopathic autoimmune hepatitis.
This study evaluates the effectiveness of low-dose corticosteroids in managing grade 2-3 immune-related hepatitis in cancer patients treated with immune checkpo…
This study aims to investigate the efficacy and safety of artificial liver support system treatment for immune checkpoint inhibitors related liver failure in pa…
VAY736 dose testing; VAY736 efficacy and safety testing.
The clinical trial aims to compare the effectiveness of ursodeoxycholic acid (UDCA) to corticosteroids in treating cholestatic hepatitis induced by immune check…
Although many studies investigated the prevalence and manifestations of HPV-B19 infection in patients with sickle cell anemia (SCA), thalassemia, and hereditary…